High mobility group box 1 protein (HMGB-1): a pathogenic role in preeclampsia?


Autoria(s): Pradervand P.A.; Clerc S.; Frantz J.; Rotaru C.; Bardy D.; Waeber B.; Liaudet L.; Vial Y.; Feihl F.
Data(s)

2014

Resumo

We evaluated whether preeclampsia is associated with elevated circulating levels of High mobility group box 1 protein (HMGB-1), a nuclear protein with proinflammatory effects when released extracellularly. We enrolled 48 women, 32 in third trimester pregnancy (16 with, 16 without preeclampsia), and 16 healthy non pregnant. In the peripheral blood of pregnant women, HMGB-1 concentration was assessed serially, before and after delivery. With or without preeclampsia, third trimester pregnancy was associated with elevated levels of HMGB-1. This elevation is exaggerated in preeclampsia. The source of HMGB-1 observed in these conditions is likely to involve tissues other than the placenta itself.

Identificador

http://serval.unil.ch/?id=serval:BIB_3E53EE74E4DA

isbn:1532-3102 (Electronic)

pmid:25043672

doi:10.1016/j.placenta.2014.06.370

isiid:000342961400017

Idioma(s)

en

Fonte

Placenta, vol. 35, no. 9, pp. 784-786

Tipo

info:eu-repo/semantics/article

article